​

FibroGen (FGEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FGEN Stock Forecast

FibroGen (FGEN) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 8932.26% increase from the last price of $0.31.

- $6 $12 $18 $24 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $0.31

FGEN Stock Rating

FibroGen stock's rating consensus is Hold, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (35.71%), 8 Hold (57.14%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Hold
Total 14 0 1 8 5 Strong Sell Sell Hold Buy Strong Buy

FGEN Price Target Upside V Benchmarks

TypeNameUpside
StockFibroGen8932.26%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.31$0.31$0.31
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 251-1--2
May, 251-1--2
Apr, 251-1--2
Mar, 251-1--2
Feb, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2023Annabel SamimyStifel Nicolaus$28.00$17.3261.66%8932.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 31, 2024William BlairMarket PerformMarket Performhold
Jan 30, 2023William BlairOutperformupgrade
Jan 05, 2023Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.11$-3.15$-3.15$-2.92$-1.53----
Avg Forecast$-1.70$-2.50$-3.37$-2.63$-0.80$-0.46$-0.38$0.25$-0.44
High Forecast$-1.67$-2.46$-3.00$-2.56$-0.74$-0.38$-0.32$0.30$-0.37
Low Forecast$-1.72$-2.54$-3.75$-2.69$-0.86$-0.52$-0.44$0.21$-0.51
Surprise %24.12%26.00%-6.53%11.03%91.25%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$176.32M$235.31M$140.73M$147.75M$29.62M----
Avg Forecast$212.12M$267.58M$130.85M$164.01M$177.84M$166.17M$178.16M$224.84M$270.40M
High Forecast$214.65M$270.78M$141.92M$184.89M$178.69M$187.32M$178.24M$230.77M$304.82M
Low Forecast$209.58M$264.39M$119.78M$143.13M$176.99M$145.02M$178.08M$218.91M$235.98M
Surprise %-16.88%-12.06%7.55%-9.91%-83.34%----

Net Income Forecast

$-550M $-430M $-310M $-190M $-70M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-189.29M$-291.03M$-295.23M$-284.23M$-153.10M----
Avg Forecast$-164.94M$-121.49M$-71.28M$-284.23M$-77.84M$-43.81M$-36.93M$24.64M$-42.81M
High Forecast$-162.39M$-25.48M$10.02M$-39.22M$-72.00M$-36.58M$-30.82M$28.71M$-35.73M
Low Forecast$-167.51M$-217.49M$-152.59M$-529.25M$-83.68M$-51.03M$-43.04M$20.56M$-49.90M
Surprise %14.76%139.56%314.16%-96.69%----

FGEN Forecast FAQ

Is FibroGen stock a buy?

FibroGen stock has a consensus rating of Hold, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that FibroGen is a neutral investment for most analysts.

What is FibroGen's price target?

FibroGen's price target, set by 14 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 8932.26% change from the previous closing price of $0.31.

How does FibroGen stock forecast compare to its benchmarks?

FibroGen's stock forecast shows a 8932.26% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for FibroGen over the past three months?

  • June 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is FibroGen’s EPS forecast?

FibroGen's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.46, marking a -69.93% decrease from the reported $-1.53 in 2024. Estimates for the following years are $-0.38 in 2026, $0.25 in 2027, and $-0.44 in 2028.

What is FibroGen’s revenue forecast?

FibroGen's average annual revenue forecast for its fiscal year ending in December 2025 is $166.17M, reflecting a 460.99% increase from the reported $29.62M in 2024. The forecast for 2026 is $178.16M, followed by $224.84M for 2027, and $270.4M for 2028.

What is FibroGen’s net income forecast?

FibroGen's net income forecast for the fiscal year ending in December 2025 stands at $-43.806M, representing a -71.39% decrease from the reported $-153M in 2024. Projections indicate $-36.931M in 2026, $24.64M in 2027, and $-42.813M in 2028.